We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » District Court Rejects ViroPharma Motion to Block Vancocin Generics
District Court Rejects ViroPharma Motion to Block Vancocin Generics
April 27, 2012
The U.S. District Court for the District of Columbia has denied ViroPharma’s motion for a temporary injunction to require the FDA to withdraw its approval of three generics of the gastrointestinal antibiotic Vancocin.